Represented Chardan Capital Markets LLC, as underwriter, in connection with a $20 million shelf take down offering of Nanosphere, Inc., a biotechnology company that specializes in targeted molecular diagnostic testing.
It looks like we may have content for your preferred language. Would you like to view this page in English?
